Nutex Health (NASDAQ:NUTX) Trading 8.3% Higher – Here’s Why

Shares of Nutex Health Inc. (NASDAQ:NUTX) were up 8.3% during mid-day trading on Wednesday . The company traded as high as $109.00 and last traded at $109.7950. Approximately 78,077 shares traded hands during trading, a decline of 60% from the average daily volume of 195,283 shares. The stock had previously closed at $101.38.

Analyst Upgrades and Downgrades

NUTX has been the subject of several analyst reports. Wall Street Zen raised Nutex Health from a “buy” rating to a “strong-buy” rating in a research note on Friday, November 28th. Weiss Ratings reissued a “hold (c)” rating on shares of Nutex Health in a research report on Monday, December 29th. Two analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $252.50.

Nutex Health Price Performance

The stock has a market cap of $728.21 million, a P/E ratio of 5.57 and a beta of -0.01. The company has a debt-to-equity ratio of 0.67, a quick ratio of 3.18 and a current ratio of 3.20. The business has a 50 day simple moving average of $160.10 and a 200-day simple moving average of $123.33.

Nutex Health (NASDAQ:NUTX) last released its earnings results on Tuesday, November 18th. The company reported $7.76 EPS for the quarter, topping analysts’ consensus estimates of ($5.43) by $13.19. The company had revenue of $243.99 million for the quarter, compared to analysts’ expectations of $221.93 million. Nutex Health had a return on equity of 37.44% and a net margin of 11.62%.

Insiders Place Their Bets

In related news, CFO Jon Christian Bates bought 750 shares of the company’s stock in a transaction on Tuesday, November 25th. The shares were purchased at an average cost of $136.71 per share, for a total transaction of $102,532.50. Following the completion of the purchase, the chief financial officer directly owned 5,638 shares in the company, valued at $770,770.98. The trade was a 15.34% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. 36.92% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Nutex Health

A number of hedge funds have recently modified their holdings of the stock. Pertento Partners LLP bought a new position in Nutex Health during the third quarter valued at $27,940,000. Topline Capital Management LLC lifted its position in shares of Nutex Health by 80.0% during the 3rd quarter. Topline Capital Management LLC now owns 556,567 shares of the company’s stock valued at $57,505,000 after buying an additional 247,436 shares during the last quarter. Marshall Wace LLP grew its stake in shares of Nutex Health by 333.4% during the 2nd quarter. Marshall Wace LLP now owns 94,548 shares of the company’s stock worth $11,770,000 after acquiring an additional 72,734 shares during the period. Millennium Management LLC increased its holdings in Nutex Health by 191.1% in the 3rd quarter. Millennium Management LLC now owns 93,396 shares of the company’s stock worth $9,650,000 after acquiring an additional 61,308 shares during the last quarter. Finally, Divisadero Street Capital Management LP purchased a new stake in Nutex Health in the 2nd quarter worth about $7,481,000. Institutional investors own 5.32% of the company’s stock.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.